BCWM
RMD icon

Bartlett & Co Wealth Management’s ResMed RMD Stock Holding History

Bartlett & Co Wealth Management’s Portfolio RMD Stock Details RMD Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q2 		$2.14K Buy
11
+9
+450% +$1.86K ﹤0.01% 1162
2026
Q1 		$419 Sell
2
-23
-92% -$5.73K ﹤0.01% 1176
2025
Q4 		$6.02K Buy
25
+13
+108% +$3.33K ﹤0.01% 989
2025
Q3 		$3.29K Buy
12
+11
+1,100% +$3K ﹤0.01% 1051
2025
Q2 		$258 Hold
1
– – ﹤0.01% 1187
2025
Q1 		$224 Buy
+1
New +$233 ﹤0.01% 1162

Other funds holding RMD

BlackRock
BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return
Vanguard Capital Management
Vanguard Capital Management Malvern, Pennsylvania $4.68T AUM
Vanguard Portfolio Management
Vanguard Portfolio Management Malvern, Pennsylvania $2.22T AUM
State Street
State Street Boston, Massachusetts $3.37T AUM 44.26% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.88T AUM 44.46% 1-Year Est. Return
Bank of New York Mellon
Bank of New York Mellon New York $609B AUM 40.19% 1-Year Est. Return
First Trust Advisors
First Trust Advisors Wheaton, Illinois $170B AUM 46.21% 1-Year Est. Return
Invesco
Invesco Atlanta, Georgia $1.26T AUM 61.52% 1-Year Est. Return
Morgan Stanley
Morgan Stanley New York $1.89T AUM 35.08% 1-Year Est. Return
Northern Trust
Northern Trust Chicago, Illinois $860B AUM 41.15% 1-Year Est. Return

Bartlett & Co Wealth Management's RMD Position: Q2 2026 in Review

Bartlett & Co Wealth Management increased its ResMed (RMD) stake by 450% in Q2 2026, buying an estimated $1.86K and bringing the position to 11 shares worth $2.14K. The position accounts for ﹤0.01% of the portfolio, ranked #1162.

Bartlett & Co Wealth Management first reported a position in RMD in Q1 2025 and has held it in 6 quarters since. The position peaked at $6.02K in Q4 2025. 887 funds tracked by Wall St. Rank hold RMD as of Q2 2026.

  • Bartlett & Co Wealth Management held 11 shares of ResMed worth $2.14K as of Q2 2026.
  • Bartlett & Co Wealth Management bought 9 ResMed shares in Q2 2026, an estimated $1.86K.
  • ResMed made up ﹤0.01% of Bartlett & Co Wealth Management's portfolio in Q2 2026, its #1162 holding.
  • Bartlett & Co Wealth Management first reported a position in ResMed in Q1 2025 and has held it in 6 quarters since.
  • Bartlett & Co Wealth Management's ResMed position peaked at $6.02K in Q4 2025.
  • 887 funds tracked by Wall St. Rank held ResMed as of Q2 2026.

Based on Bartlett & Co Wealth Management's 13F filing for Q2 2026, filed 24 Jul 2026.